CLINICAL_TRIALS
trial_result
· 2018-09-11
Clinical Trial Update: Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER) [Phase 2]
Summary
A Phase 2 clinical trial investigating the neuroprotective effects of resveratrol in Gulf War Illness.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VISN 17 Center of Excellence | Conditions: Gulf War Illness | Phase 2 | Status: UNKNOWN